Literature DB >> 18726668

High seroprevalence of varicella, measles, mumps, rubella and pertussis antibodies in first-grade medical students.

Maja Socan1, Natasa Berginc.   

Abstract

OBJECTIVE: The aim of the study was to investigate seropositivity for five vaccine-preventable communicable diseases - varicella, measles, mumps, rubella and pertussis - in a sample of first-grade medical students.
METHODS: A total of 256 students were tested for varicella IgG antibodies. In addition, 138 of the students were serologically screened for measles, mumps, rubella and pertussis antibodies. Data on vaccination and history of measles, mumps, rubella and pertussis were collected.
RESULTS: Immunity to varicella, measles, mumps and rubella was established in 97.6%, 96.4%, 97.8% and 99.3% participants, respectively. Anti-pertussis toxin antibodies were detected in 81.2% of the students.
CONCLUSIONS: The rates of varicella, measles, mumps and rubella immunity in first-grade medical students are very high. To identify those students who need vaccination before commencing practical work in healthcare facilities, a meticulous disease and vaccination history should be taken and medical records should be reviewed. Medical students providing no written evidence of adequate vaccination status should be serologically tested and vaccinated if necessary.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18726668     DOI: 10.1007/s00508-008-1005-6

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  25 in total

1.  Prevalence of serological markers against measles, rubella, varicella, hepatitis B, hepatitis C, and human immunodeficiency virus among medical residents in Mexico.

Authors:  M A Villasís-Keever; L A Peña; G Miranda-Novales; T Alvarez y Muñoz; L Damasio-Santana; G López-Fuentes; J L Girón-Carrillo
Journal:  Prev Med       Date:  2001-05       Impact factor: 4.018

2.  Occupational risk of infection by varicella zoster virus in Belgian healthcare workers: a seroprevalence study.

Authors:  G Vandersmissen; G Moens; R Vranckx; A de Schryver; P Jacques
Journal:  Occup Environ Med       Date:  2000-09       Impact factor: 4.402

3.  Screening healthcare workers for varicella-zoster virus: can we trust the history?

Authors:  Maha Almuneef; Ziad A Memish; Mostafa E Abbas; Hanan H Balkhy
Journal:  Infect Control Hosp Epidemiol       Date:  2004-07       Impact factor: 3.254

4.  Susceptibility of medical students to vaccine-preventable viral diseases: a serological study.

Authors:  Junko Kukino; Toshio Naito; Kazunori Mitsuhashi; Hiroko Oshima; Sakae Sekiya; Hiroshi Isonuma; Kazuyoshi Watanabe; Takashi Dambara; Yasuo Hayashida
Journal:  J Infect Chemother       Date:  2004-12       Impact factor: 2.211

5.  Prevalence of childhood exanthematic disease antibodies in paramedical students: need of vaccination.

Authors:  Andrea Trevisan; Marta Morandin; Clara Frasson; Paolo Paruzzolo; Elisabetta Davanzo; Livio Di Marco; Andrea Fabrello; Matteo Borella-Venturini
Journal:  Vaccine       Date:  2005-08-09       Impact factor: 3.641

6.  Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective?

Authors:  Aysel Celikbas; Onder Ergonul; Sabahat Aksaray; Nilden Tuygun; Harika Esener; Gonul Tanir; Sebnem Eren; Nurcan Baykam; Engin Guvener; Basak Dokuzoguz
Journal:  Am J Infect Control       Date:  2006-11       Impact factor: 2.918

7.  The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.

Authors:  Hester de Melker; Guy Berbers; Susan Hahné; Hans Rümke; Susan van den Hof; Ardine de Wit; Hein Boot
Journal:  Vaccine       Date:  2006-02-24       Impact factor: 3.641

8.  Seroprevalence and immunization history of selected vaccine preventable diseases in medical students.

Authors:  Gurli Baer; Jan Bonhoeffer; Urs B Schaad; Ulrich Heininger
Journal:  Vaccine       Date:  2005-03-14       Impact factor: 3.641

9.  Chickenpox outbreak among the staff of a large, urban adult hospital: costs of monitoring and control.

Authors:  J L Faoagali; D Darcy
Journal:  Am J Infect Control       Date:  1995-08       Impact factor: 2.918

10.  Antibody responses to pneumococcal and hemophilus vaccinations in splenectomized patients with hematological malignancies or trauma.

Authors:  Karin Eigenberger; Christian Sillaber; Manfred Greitbauer; Harald Herkner; Hermann Wolf; Wolfgang Graninger; Rainer Gattringer; Heinz Burgmann
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

View more
  6 in total

1.  Prevalence of measles, mumps, rubella, and varicella susceptibility among health science students in a University in India.

Authors:  G Arunkumar; K E Vandana; Nalini Sathiakumar
Journal:  Am J Ind Med       Date:  2012-03-29       Impact factor: 2.214

Review 2.  A global perspective of vaccination of healthcare personnel against measles: systematic review.

Authors:  Amy Parker Fiebelkorn; Jane F Seward; Walter A Orenstein
Journal:  Vaccine       Date:  2013-11-24       Impact factor: 3.641

3.  Incidence and effects of Varicella Zoster Virus infection on academic activities of medical undergraduates--a five-year follow-up study from Sri Lanka.

Authors:  Suneth B Agampodi; Samath D Dharmaratne; Vasanthi Thevanesam; Sameera Dassanayake; Prabhashini Kumarihamy; Ashani Ratnayake
Journal:  BMC Infect Dis       Date:  2010-05-14       Impact factor: 3.090

4.  Seroprevalence of IgG Antibodies against Mumps in Bulgarian Children under 18 Years of Age.

Authors:  Milena Karcheva; Galya Gancheva
Journal:  Balkan Med J       Date:  2013-03-01       Impact factor: 2.021

5.  Evaluation of a vaccination seminar in regard to medical students' attitudes and their theoretical and practical vaccination-specific competencies.

Authors:  Vera Rill; Björn Steffen; Sabine Wicker
Journal:  GMS J Med Educ       Date:  2020-06-15

6.  Evaluation of Immunity to Measles in a Cohort of Medical Students in Rome, Italy.

Authors:  Luca Coppeta; Giorgia Biondi; Piergiorgio Lieto; Antonio Pietroiusti
Journal:  Vaccines (Basel)       Date:  2019-12-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.